Cite
MLA Citation
Till Koch et al.. “Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.” Lancet infectious diseases, vol. 20, no. 7, 2020, pp. 827–838. http://access.bl.uk/ark:/81055/vdc_100103928661.0x00000c